COVAXIN
- India
ICMR rejects BHU study on Covaxin, says findings misleading
New Delhi: The Indian Council of Medical Research (ICMR) has rejected a recent study led by Banaras Hindu University (BHU), which claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre…
- News
Over 30% Covaxin takers suffered from health issues after 1 year, claims BHU study
New Delhi: Nearly one-third of the individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study conducted by a…
- India
No link between Covid vaccines used in India and heart attack risk: Study
New Delhi: There is no association between the Covid-19 vaccines used in India — Covishield and Covaxin — and increase in the risk of heart attacks, according to an observational study which…
- India
Covaxin booster safe, necessary for lasting immunity-ICMR study, says govt
New Delhi: An ICMR study has indicated that a booster dose of Covaxin is safe and necessary to ensure persistent immunity to minimise breakthrough infections of COVID-19, due to newly emerging variants,…
- Delhi
DGCI approves market authorisation of Serum Institute’s Covovax as booster dose
Delhi: The Drugs Controller General of India (DCGI) has approved the market authorisation of Serum Institute of India’s (SII) COVID-19 vaccine Covovax as a heterologous booster dose. This vaccine can be taken…
- Hyderabad
Bharat Biotech’s intranasal COVID-19 vaccine priced at Rs 800
Hyderabad: Vaccine maker Bharat Biotech’s intranasal vaccine for COVID-19, the first in the world, is scheduled to be introduced in the country as a booster dose shortly. The vaccine, iNCOVACC (BBV154), is…
- India
Corbevax recommended as booster for adults vaccinated with Covishield, Covaxin
New Delhi: A government panel on Covid immunisation has recommended allowing Biological E’s Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin, official sources said on Tuesday.…
- Health
Covaxin can help control virus load, reduce disease severity: Study
New Delhi: Scientists have found that Covaxin, which is an inactivated whole-virion vaccine, induces robust immune memory to SARS-CoV-2 and its variants of concern that persists for at least six months after…
- Hyderabad
Covaxin safe for children aged 2-18 years: Bharat Biotech
Hyderabad: Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study,…
- Hyderabad
Hyderabad based Corbevax gets DGCI nod as COVID-19 booster for 18+
New Delhi: Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous Covid-19…
- India
Germany approves Bharat Biotech’s Covaxin
New Delhi: Germany on Thursday approved the ‘Made in India’ Bharat Biotech’s Covid vaccine Covaxin. “Covaxin has been approved by Germany. The entrants will no longer need proof of vaccination as the Federal…
- Hyderabad
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Hyderabad: The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for the age group of 6-12 years. The Hyderabad-based Pharma company Bharat…
- Top Stories
SII, Bharat Biotech cut prices of COVID-19 vaccines for pvt hospitals to Rs 225
New Delhi: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs…
- India
Covid precaution dose for 18+ age group at private vaccination centres from Apr 10
New Delhi: Precaution dose of COVID-19 vaccines will be available to all aged above 18 years at private vaccination centres from April 10, the Union Health Ministry announced on Friday. According to…
- Hyderabad
Bharat Biotech temporarily slows down COVAXIN production
Hyderabad: Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.…
- 1
- 2